TRDA Entrada Therapeutics, Inc.
Fundamentals / CIK 0001689375 / USDEntrada Therapeutics, Inc. reported $3.98M in revenue and a net loss of $161.4M for the trailing twelve months ended September 30, 2026 (down 43.9% year over year), with a -4303.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TRDA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$3.98M -43.9% YoY
-
Operating Income TTM-$171.2M -4303.8% margin
-
Net Income TTM-$161.4M -4058.0% net margin
-
Diluted EPS TTM-$3.81 Split-adjusted
-
Free Cash Flow TTM-$136.3M -3428.1% FCF margin
-
Cash & ST Investments Sep 30, 2026$112.2M Total debt: $47.31M
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $25.42M | $210.8M | $129.0M | -- | -- | -- |
| Research & Development | $142.3M | $125.3M | $99.88M | $66.61M | $35.93M | $21.10M |
| Total Operating Expenses | $183.3M | $163.8M | $132.2M | $97.25M | $51.13M | $26.67M |
| Operating Income | -$157.9M | $47.01M | -$3.16M | -$97.25M | -$51.13M | -$26.67M |
| EBITDA | -$153.8M | $50.78M | -$321K | -$95.35M | -$50.01M | -$26.34M |
| Income Tax Expense | $924K | $859K | $18.74M | $0 | $0 | $0 |
| Net Income | -$143.8M | $65.63M | -$6.68M | -$94.62M | -$51.16M | -$26.52M |
| Basic EPS | -$3.47 | $1.76 | -$0.20 | -$3.02 | -$8.16 | -$24.00 |
| Diluted EPS | -$3.47 | $1.68 | -$0.20 | -$3.02 | -$8.16 | -$24.00 |
| Basic Shares Outstanding | 41.4M | 37.3M | 33.1M | 31.3M | 6.3M | 1.1M |
| Diluted Shares Outstanding | 41.4M | 39.0M | 33.1M | 31.3M | 6.3M | 1.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $905K | $898K | $875K | $1.30M | $1.61M | $1.95M | $20.56M | $37.40M |
| Research & Development | $32.37M | $35.37M | $33.05M | $33.96M | $38.36M | $37.88M | $32.07M | $33.41M |
| Total Operating Expenses | $42.59M | $45.86M | $43.18M | $43.51M | $48.66M | $48.80M | $42.35M | $43.27M |
| Operating Income | -$41.69M | -$44.96M | -$42.30M | -$42.21M | -$47.05M | -$46.85M | -$21.79M | -$5.87M |
| EBITDA | -$40.99M | -$44.16M | -$41.50M | -$41.32M | -$45.85M | -$45.75M | -$20.84M | -$4.88M |
| Income Tax Expense | $27K | $35K | $38K | $92K | $654K | $178K | $0 | -$1.87M |
| Net Income | -$39.74M | -$42.76M | -$39.72M | -$39.16M | -$44.13M | -$43.10M | -$17.35M | $1.13M |
| Basic EPS | -$0.94 | -$1.01 | -$0.95 | -- | -$1.06 | -$1.04 | -$0.42 | -- |
| Diluted EPS | -$0.94 | -$1.01 | -$0.95 | -- | -$1.06 | -$1.04 | -$0.42 | -- |
| Basic Shares Outstanding | 42.4M | 42.2M | 41.8M | -- | 41.5M | 41.3M | 41.1M | -- |
| Diluted Shares Outstanding | 42.4M | 42.2M | 41.8M | -- | 41.5M | 41.3M | 41.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $90.39M | $101.2M | $67.60M | $45.16M | $291.1M | $39.05M |
| Short-Term Investments | -- | -- | -- | -- | $0 | -- |
| Cash & Short-Term Investments | $295.7M | $420.0M | $352.0M | $188.7M | $291.1M | $39.05M |
| Total Current Assets | $306.3M | $440.0M | $369.8M | $209.9M | $298.7M | $39.95M |
| Property, Plant & Equipment, Net | $7.31M | $10.93M | $11.19M | $7.68M | $6.26M | $3.04M |
| Other Non-Current Assets | $70K | $284K | $2.79M | $5.21M | $872K | $541K |
| Total Non-Current Assets | $71.13M | $86.28M | $99.42M | $42.18M | $7.13M | $3.58M |
| Total Assets | $377.4M | $526.3M | $469.2M | $252.1M | $305.8M | $43.53M |
| Accounts Payable | $2.29M | $4.26M | $3.28M | $5.99M | $706K | $1.60M |
| Deferred Revenue (Current) | $342K | $13.65M | $132.3M | $0 | -- | -- |
| Total Current Liabilities | $24.45M | $39.48M | $158.8M | $21.97M | $6.72M | $3.36M |
| Total Non-Current Liabilities | $46.79M | $58.16M | $68.04M | $17.53M | $396K | $0 |
| Total Liabilities | $71.25M | $97.64M | $226.8M | $39.50M | $7.12M | $3.36M |
| Total Debt (incl. Leases) | $50.93M | $59.21M | $68.23M | $25.94M | -- | -- |
| Common Stock | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | -- |
| Retained Earnings | -$273.1M | -$129.3M | -$195.0M | -$188.3M | -$93.67M | -$42.51M |
| Accumulated Other Comp. Income | $652K | -$43K | $195K | -$2.06M | $0 | -- |
| Total Stockholders' Equity | $306.1M | $428.7M | $242.4M | $212.6M | $298.7M | -$41.49M |
| Total Equity | $306.1M | $428.7M | $242.4M | $212.6M | $298.7M | -$41.49M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $112.2M | $99.28M | $76.44M | $90.39M | $93.29M | $72.48M | $67.84M | $101.2M |
| Cash & Short-Term Investments | $193.0M | $223.0M | $254.9M | $295.7M | $326.8M | $354.0M | $382.5M | $420.0M |
| Total Current Assets | $203.0M | $232.7M | $266.9M | $306.3M | $338.3M | $369.1M | $403.2M | $440.0M |
| Property, Plant & Equipment, Net | $5.21M | $5.72M | $6.51M | $7.31M | $8.41M | $9.81M | $10.67M | $10.93M |
| Other Non-Current Assets | $123K | $118K | $90K | $70K | $163K | $199K | $239K | $284K |
| Total Non-Current Assets | $63.93M | $66.17M | $68.65M | $71.13M | $74.64M | $79.64M | $83.29M | $86.28M |
| Total Assets | $266.9M | $298.9M | $335.5M | $377.4M | $412.9M | $448.8M | $486.5M | $526.3M |
| Accounts Payable | $4.87M | $3.75M | $2.93M | $2.29M | $3.17M | $1.86M | $2.19M | $4.26M |
| Deferred Revenue (Current) | $98K | $173K | $254K | $342K | $351K | $689K | $1.35M | $13.65M |
| Total Current Liabilities | $25.86M | $21.37M | $19.20M | $24.45M | $24.02M | $19.80M | $18.43M | $39.48M |
| Total Non-Current Liabilities | $42.69M | $44.09M | $45.47M | $46.79M | $48.16M | $49.48M | $50.79M | $58.16M |
| Total Liabilities | $68.56M | $65.47M | $64.66M | $71.25M | $72.18M | $69.28M | $69.22M | $97.64M |
| Total Debt (incl. Leases) | $47.31M | $48.54M | $49.75M | $50.93M | $52.40M | $54.74M | $57.00M | $59.21M |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K |
| Retained Earnings | -$395.3M | -$355.6M | -$312.8M | -$273.1M | -$233.9M | -$189.8M | -$146.7M | -$129.3M |
| Accumulated Other Comp. Income | -$56K | $66K | $246K | $652K | $621K | $400K | $437K | -$43K |
| Total Stockholders' Equity | $198.3M | $233.4M | $270.9M | $306.1M | $340.7M | $379.5M | $417.3M | $428.7M |
| Total Equity | $198.3M | $233.4M | $270.9M | $306.1M | $340.7M | $379.5M | $417.3M | $428.7M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$143.8M | $65.63M | -$6.68M | -$94.62M | -$51.16M | -$26.52M |
| Depreciation & Amortization | $4.10M | $3.77M | $2.84M | $1.90M | $1.12M | $326K |
| Stock-Based Compensation | $19.61M | $17.91M | $13.11M | $9.89M | $2.53M | $325K |
| Change in Payables | -$1.80M | $991K | -$2.81M | $5.29M | -$715K | $631K |
| Operating Cash Flow | -$128.5M | -$41.56M | $139.8M | -$93.79M | -$50.86M | -$25.57M |
| Capital Expenditure | -$1.04M | -$3.16M | -$5.61M | -$2.89M | -$4.58M | -$2.32M |
| Free Cash Flow | -$129.6M | -$44.72M | $134.2M | -$96.67M | -$55.44M | -$27.89M |
| Purchases of Investments | -$141.6M | -$437.7M | -$407.2M | -$222.0M | $0 | -- |
| Investing Cash Flow | $116.8M | -$27.80M | -$138.4M | -$148.7M | -$4.58M | -$2.32M |
| Financing Cash Flow | $887K | $103.0M | $21.04M | $479K | $307.5M | $50.09M |
| Net Change in Cash | -$10.82M | $33.61M | $22.45M | -$242.0M | $252.0M | $22.20M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$39.74M | -$42.76M | -$39.72M | -$39.16M | -$44.13M | -$43.10M | -$17.35M | $1.13M |
| Depreciation & Amortization | $700K | $800K | $805K | $886K | $1.20M | $1.10M | $946K | $992K |
| Stock-Based Compensation | $4.78M | $5.15M | $4.74M | $4.36M | $5.12M | $5.05M | $5.09M | $4.70M |
| Change in Payables | $1.12M | $816K | $641K | -$877K | $1.31M | -$321K | -$1.91M | $2.85M |
| Operating Cash Flow | -$29.96M | -$32.46M | -$41.70M | -$32.20M | -$28.31M | -$29.49M | -$38.51M | -$31.61M |
| Capital Expenditure | -$161K | -$11K | -$44K | $207K | $171K | -$275K | -$1.14M | -$635K |
| Free Cash Flow | -$30.12M | -$32.47M | -$41.74M | -$32.00M | -$28.14M | -$29.76M | -$39.65M | -$32.24M |
| Purchases of Investments | -$7.92M | -$3.92M | -$11.82M | -$18.47M | -$26.57M | -$16.55M | -$80.02M | -$64.50M |
| Investing Cash Flow | $42.92M | $54.95M | $26.99M | $29.12M | $49.11M | $33.80M | $4.78M | $53.37M |
| Financing Cash Flow | $0 | $350K | $100K | $192K | $8.0K | $337K | $350K | $1.40M |
| Net Change in Cash | $12.96M | $22.84M | -$14.61M | -$2.89M | $20.80M | $4.64M | -$33.37M | $23.16M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Operating Margin | -621.1% | 22.3% | -2.5% | -- | -- | -- |
| Net Profit Margin | -565.5% | 31.1% | -5.2% | -- | -- | -- |
| Return on Equity (ROE) | -47.0% | 15.3% | -2.8% | -44.5% | -17.1% | -- |
| Return on Assets (ROA) | -38.1% | 12.5% | -1.4% | -37.5% | -16.7% | -60.9% |
| Current Ratio | 12.53x | 11.15x | 2.33x | 9.55x | 44.46x | 11.89x |
| Quick Ratio | 12.09x | 10.64x | 2.22x | 8.59x | 43.32x | 11.62x |
| Debt to Equity | 0.17x | 0.14x | 0.28x | 0.12x | -- | -- |
| Revenue Growth (YoY) | -87.9% | +63.4% | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -435.9% | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -319.0% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -297.2% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -129.7% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -133.3% | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4303.8% | -3767.1% | -3109.3% | -621.1% | -197.6% | -121.0% | 2.4% | 22.3% |
| Net Profit Margin | -4058.0% | -3537.7% | -2895.1% | -565.5% | -168.2% | -92.3% | 14.4% | 31.1% |
| Return on Equity (ROE) | -81.4% | -71.0% | -61.3% | -47.0% | -30.4% | -19.3% | 5.9% | 15.3% |
| Return on Assets (ROA) | -60.5% | -55.5% | -49.5% | -38.1% | -25.1% | -16.3% | 5.1% | 12.5% |
| Current Ratio | 7.85x | 10.89x | 13.90x | 12.53x | 14.08x | 18.64x | 21.88x | 11.15x |
| Quick Ratio | 7.46x | 10.43x | 13.28x | 12.09x | 13.61x | 17.88x | 20.75x | 10.64x |
| Debt to Equity | 0.24x | 0.21x | 0.18x | 0.17x | 0.15x | 0.14x | 0.14x | 0.14x |
| Revenue Growth (YoY) | -43.9% | -53.9% | -95.7% | -96.5% | -91.8% | -97.9% | -65.2% | -10.6% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -187.7% | -203.2% | -219.6% |
| Net Income Growth (YoY) | -- | -- | -- | -3562.8% | -- | -178.3% | -173.8% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -164.6% | -160.0% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -174.0% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -176.7% | -- | -- |